Company intelligence / Profile preview

Himore Medical

Ownership: Private
Development stage: Commercial

Overview

The Cardiopad, developed by Himore Medical under Arthur Zang, is Africa’s first medical tablet for remote cardiac diagnostics. It enables healthcare workers in rural areas to perform ECGs and transmit results wirelessly to urban cardiologists for expert interpretation. The device has been installed in several hospitals across Cameroon, improving access to life-saving cardiac care for underserved populations.

Therapeutic areas: Cardiovascular
Modalities: Device
Industry: Physiological Monitoring

Partnerships

No major pharmaceutical or biotech partnerships reported; focus has been on local deployment and government/NGO support.

Beyond the preview

Go deeper on Himore Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Himore Medical.

Explore the full profile